Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Tables)

v3.7.0.1
Net Loss per Share (Tables)
6 Months Ended
Jun. 30, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics, Inc. and Subsidiaries for the three and six months ended June, 2017 and 2016 (in thousands except share and per share amounts):
 
 
 
Three months ended June 30, 2017
 
Six months ended June 30, 2017
 
 
 
Net loss
 
Shares
 
Per Share
 
Net Loss
 
Shares
 
Per Share
 
 
 
(Numerator)
 
(Denominator)
 
Amount
 
(Numerator)
 
(Denominator)
 
Amount
 
Net loss - Basic
 
$
(4,255)
 
 
123,005,220
 
$
(0.03)
 
$
(7,101)
 
 
120,241,593
 
$
(0.06)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive shares related to warrants
 
$
-
 
 
-
 
$
-
 
$
-
 
 
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss - Dilutive
 
$
(4,255)
 
 
123,005,220
 
$
(0.03)
 
$
(7,101)
 
 
120,241,593
 
$
(0.06)
 
  
 
 
Three months ended June 30, 2016
 
Six months ended June 30, 2016
 
 
 
Net loss
 
Shares
 
Per Share
 
Net Loss
 
Shares
 
Per Share
 
 
 
(Numerator)
 
(Denominator)
 
Amount
 
(Numerator)
 
(Denominator)
 
Amount
 
Net loss - Basic
 
$
(5,764)
 
 
91,015,733
 
$
(0.06)
 
$
(16,842)
 
 
90,921,243
 
$
(0.18)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in fair value of warrant liability
 
$
(3,513)
 
 
-
 
$
-
 
$
(3,015)
 
 
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive shares related to warrants
 
$
-
 
 
2,914,807
 
$
-
 
$
-
 
 
1,729,974
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss - Dilutive
 
$
(9,277)
 
 
93,930,540
 
$
(0.10)
 
$
(19,857)
 
 
92,651,215
 
$
(0.21)